![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Luke Jason John Ott Patrick Alexander
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.14, Iss.18, 2013-12, pp. : 2457-2462
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Inhibitors of Checkpoint Kinase 2
Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Protein kinase inhibitors in melanoma
By Eigentler Thomas K Meier Friedegund Garbe Claus
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. :